The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weight loss and has been shown to reduce apnea events." ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023. Although the new FDA green light doesn’t expand the ...

The the US Food and Drug Administration (FDA) has approved the first medication ... “Zepbound promotes weight loss and has been shown to reduce apnea events,” Troxel noted.

The FDA first approved Zepbound to treat obesity in November ... to treat Type 2 diabetes and became popular as an off-label weight-loss treatment. Tirzepatide works by stimulating two hormones ...

Rapid weight loss has been a hallmark of these medications ... to easing knee arthritis pain to curbing asthma. Friday's FDA approval of Zepbound for treating moderate to severe sleep apnea ...

Tirzepatide is also the compound in the diabetes drug Mounjaro. Advertising Even before the FDA approval, some doctors have ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.